medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2016, Number 11

<< Back Next >>

Ginecol Obstet Mex 2016; 84 (11)

Polipectomy by diagnostic hysteroscopy in postmenopausal women

Pato-Mosquera M, Carballo-Núñez E, Vázquez-Rodríguez M, Rivas-Duro J

Language: Spanish
References: 23
Page: 704-710
PDF size: 283.43 Kb.


ABSTRACT

Background: When an endometrial polyp is suspected by transvaginal ultrasound in postmenopausal women with bleeding, diagnostic hysteroscopy is the procesure to apply in order to assess the endometrial cavity, remove the polyp and to make a histologic study. In asymptomatic patients this clinical practice is not clear at all.
Objetive: To evaluate the difference between asymptomatic and symptomatic women in terms of risk factors and the incidence of premalignant and malignant lesions in both groups
Material and Method: Retrospective observational descriptive study of 130 patients with a diagnosis of endometrial polyp based on diagnostic hysteroscopy.
Results: 56.9% (74) were asymptomatic and 43.1% (56) were symptomatic. There were no statistical differences between both groups in the percentage of arterial hypertension (36.5 vs 33.9%), diabetes mellitus (14.9 vs 10.7%), and breast cancer (14.9 vs 17.9%). The most frequent anatomopathologic diagnostic in asymptomatic women was endometrial polyp in 93.2% of the patients while in symptomatic this was confirmed in the 80% of the cases with a p = 0.026. There were 5.5% of malignant or premalignant pathology in symptomatic patients and 2.8% in asymptomatic with no statistical significance between them.
Conclusions: Despite of not having differences between both groups of patients the diagnostic hysteroscopy indication should be individualized because of the rare incidence of premalignant or malignant pathology in asymptomatic women.


REFERENCES

  1. Lieng M, Istre O, Qvigstad E. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand 2010;89:992-1002.

  2. Mossa B, Torcia F, Avenoso F, Tucci S, Marziani R. Occurrence of malignancy in endometrial polyps during postmenopause. Eur J Gynaecol Oncol 2010;31(2):165-168.

  3. Savelli L, De iaco P, Santini D, Rosati F, Ghi T, Pignoti E, Bovicelli L. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 2003;188:927.

  4. Antunes A, Costa-Paiva L, Arthuso M, Costa JV, Pinto-Neto AM. Endometrial polyps in pre and postmenopausal women: factors associated with the malignancy. Maturitas 2007;57:415.

  5. Pato M, Vázquez M, Pérez M, García MJ, Blanco S. Indicaciones y resultados de la histeroscopia diagnóstica ambulatoria en el Complexo Hospitalario Universitario de Ourense. Gynecol Obstet Mex 2013;81:382-388.

  6. Vázquez M, Pato M, García MJ. Hallazgos histeroscópicos en pacientes postmenopáusicas en el Complexo Hospitalario Universitario de Ourense. Clin Invest Gin Obstet 2015;42(3):101-106.

  7. Domingues AP, Lopes H, Diaz I, Freire C. Endometrial polyps in postmenopausal women. Acta Obstet Gynecol Scand 2009;88:618-620.

  8. Salim S, Nesbitt-Hawes E, Campbell N, Abott J. Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol 2011;18(5):569- 581.

  9. Cruz Lee S, Kaunitz A, Sanchez-Ramos L, Rhatiga R. The oncogenic potential of endometrial polyps. Obstet Gynecol 2010;116(5):1197-1205.

  10. Ferrazi E, Zupi E, Leone F, Savelli L, Omodei U et al. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. Am J Obstet Gynecol 2009;200:235.e1-235.e6.

  11. Goldstein SR, Monteagudo A, Popiolek D, Mayberry P, Timor-Tritsch I. Evaluation of endometrial polyps. Am J Obstet Gynecol 2002;186:669-674.

  12. Golan A, Cohen-Sahar B, Keidar R, Condrea A, Ginath A. Endometrial polyps: syntomatology, menopausal status and malignancy. Gynecol Obstet Invest 2010;70:107-112.

  13. Kassab A, Trotter P, Fox R. Risk of cancer in symptomatic postmenopausal women with endometrial polyps at scan. J Obstet Gynaecol 2008;28(5):522-525.

  14. Shushan A, Revel A, Rijansky N. How often are endometrial polyps malignant? Gynecol Obstet Invest 2004;58:212-215.

  15. Matchinger R, Korach J, Padoa A. Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps. Risk factors for premalignancy and malignancy. Int J Gynecol Cancer 2005;15:325-328.

  16. Bakour SH, Khan KS, Gupta GK. The risk of premalignant and malignant pathology in endometrial polyps. Acta Obstet Gynecol Scand 200;79:317-320.

  17. Lev-Sagie A, Haman Y, Imba T, Hurwitx A, Lavy Y. The significance of intrauterine lesions detected by ultrasound in asymptomatic postmenopausal patients. BJOG 2005;112:379-381.

  18. Orvieto R, Bar-Hava I, Dicker D,Bar J, Ben-Rafael Z. Endometrial polyp during menopause: characterization and significance. Acta Obstet Gynecol 1999;78:883-886.

  19. Papadia A, Gerbaldo D, Fulcheri F, Ragni N, Menoni S, Zanardi S. The risk of premalignant and malignant pathology in endometrial polyps: should every polyp be resected? Minerva Ginecol 2007;59:117-124.

  20. Wang JH, Zhao J, Lin J. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. J Minim Invasive Gynecol 2010;17:53-58.

  21. Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N et al. Clinical parameters linked with malignancy in endometrial polyps. J Minim Invasive Gynecol 2007;14:189-194.

  22. Protocolo SEGO de histeroscopia en consulta 2013. Disponible en: www.campussego.com/images/documentos/ protocolos/Endoscopia_Ginecologica/histeroscopia%20 en%20consulta%202013.pdf

  23. Uptodate. Steward E. Endometrial polyps. Sept 03, 2015. Disponible en: http://www.uptodate.com




2020     |     www.medigraphic.com